Ozlem Tumer Eke
Angel Investor · at Arya Ventures
Istanbul, Turkey
Ozlem Tumer Eke is an angel Investor.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Ozlem Tumer Eke invests in
Stages Ozlem Tumer Eke invests in
Countries Ozlem Tumer Eke invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $850k–$2M
- Pre-Seed
- $495k–$1M
Investment Focus
Industry
- Biotechnology 3 (38%)
- AgTech 1 (13%)
- Beauty 1 (13%)
- Software 1 (13%)
- Wellness 1 (13%)
Stage
- Seed 4 (50%)
- Pre-Seed 2 (25%)
- Grant 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| reprai is the pharma-native AI built to automate and optimize the operations of pharmaceutical companies. The company is dedicated to making pharmaceutical operations smarter, faster, and more efficient than ever before. | $1M / Pre-Seed / Sep 01, 2025 | ||
| Text2Test is an AI-based approach that allows for the creation of executable, maintainable, and self-healing end-to-end tests using unrestricted plain language descriptions without a need for technical expertise. | $495K / Pre-Seed / Nov 29, 2024 | ||
| F4e is an employee performance management platform that helps to manage and improve employee performance by using AI. | $1M / Seed / Aug 17, 2024 | ||
| Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness. | $2M / Seed / Aug 16, 2024 | ||
| PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $1.1M / Seed / Mar 08, 2024 | ||
| Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment. | $878K / Grant / Dec 21, 2022 | ||
| Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment. | $850K / Seed / Dec 20, 2022 | ||
| See all 8 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ozlem Tumer Eke invest in?
Ozlem Tumer Eke invests primarily in Biotechnology, AgTech and Beauty startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Ozlem Tumer Eke invest in?
Ozlem Tumer Eke typically joins rounds of $850k–$2M at Seed and $495k–$1M at Pre-Seed. These are whole funding-round sizes, not Ozlem Tumer Eke's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Ozlem Tumer Eke took part in.
How do I contact Ozlem Tumer Eke?
Public channels for Ozlem Tumer Eke include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ozlem Tumer Eke last invest?
The most recent investment recorded for Ozlem Tumer Eke closed in Sep 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
